Xtandi 80 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB25FZQ01
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $8,339
Award facts
- Contract value 100% obligated
- $8,339.18 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $8,339.18 by the Defense Logistics Agency (DLA) on August 11, 2025, for the supply of Xtandi 80 mg tablets (60-count units). The contract utilizes a firm fixed-price structure with no set-aside designation and is scheduled for completion by August 12, 2025. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, a $499,999,999 single-award vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products supporting military health facilities worldwide.
Xtandi is a branded oncology medication used in prostate cancer treatment, reflecting the company's established portfolio in supplying specialized prescription drugs to Department of Defense healthcare sites. The DLA's pharmaceutical supply chain relies on vendors like DMS Pharmaceutical Group to ensure consistent access to critical medications for military medical facilities across the globe. This delivery order represents routine procurement activity under the existing IDC framework, demonstrating the contractor's continued role as a key supplier of prescription medications and pharmacy services to federal healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FZQ01?
SPE2DB25FZQ01 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 11, 2025.
How much is contract SPE2DB25FZQ01 worth?
The government has obligated $8,339 on SPE2DB25FZQ01.
Is contract SPE2DB25FZQ01 an order under another contract?
Yes. SPE2DB25FZQ01 is a delivery order under SPE2DB22D9102, an indefinite delivery contract.
Was contract SPE2DB25FZQ01 competed?
The extent of competition for SPE2DB25FZQ01 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award